Non-Invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial
Status:
Completed
Trial end date:
2019-07-23
Target enrollment:
Participant gender:
Summary
The primary aim of this study is to determine if doxycycline (100 mg bid) will inhibit (by at
least 40%) the increase in greatest transverse diameter of small abdominal aortic aneurysms
(3.5-5.0 cm in men, 3.5-4.5 cm in women) over a 24-month period of observation in comparison
to a placebo-treated control group.
Phase:
Phase 2
Details
Lead Sponsor:
University of Maryland University of Maryland, Baltimore